Gilead and Glympse Bio announce strategic collaboration for use of biomarker technology in NASH clinical development

Image: Gilead and Glympse Bio have announced strategic collaboration for use of biomarker technology in NASH clinical development. Photo: courtesy of José R Valverde from Pixabay.